| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Economics of lipid lowering in primary prevention: lessons from the West of Scotland Coronary Prevention Study
|
Shepherd, James
|
|
2001
|
87 |
5S1 |
p. 19-22
4 p.
|
artikel
|
| 2 |
Introduction
|
Gotto Jr., Antonio M.
|
|
2001
|
87 |
5S1 |
p. 1-
1 p.
|
artikel
|
| 3 |
Novel approaches to lipid lowering: what is on the horizon?
|
Brown, W.Virgil
|
|
2001
|
87 |
5S1 |
p. 23-27
5 p.
|
artikel
|
| 4 |
Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor 1 1 CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.
|
McTaggart, Fergus
|
|
2001
|
87 |
5S1 |
p. 28-32
5 p.
|
artikel
|
| 5 |
Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management∗ ∗ This article represents one side of a debate on the role of lipid subfractions in cardiovascular risk management; the opposing argument can be found in the accompanying article by Terje R. Pedersen, MD, PhD.
|
Assmann, Gerd
|
|
2001
|
87 |
5S1 |
p. 2-7
6 p.
|
artikel
|
| 6 |
Pro and con: low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid management∗ ∗ This article represents one side of a debate regarding the role of lipid subfractions in cardiovascular risk management; the opposing argument can be found in the accompanying article by Gerd Assmann, MD.
|
Pedersen, Terje R
|
|
2001
|
87 |
5S1 |
p. 8-12
5 p.
|
artikel
|
| 7 |
Statin therapy and reductions in low-density lipoprotein cholesterol: initial clinical data on the potent new statin rosuvastatin 1 1 CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.
|
Olsson, Anders G
|
|
2001
|
87 |
5S1 |
p. 33-36
4 p.
|
artikel
|
| 8 |
Statin therapy: where are we? where do we go next?
|
Gotto Jr., Antonio M
|
|
2001
|
87 |
5S1 |
p. 13-18
6 p.
|
artikel
|
Tijdschrift beschrijving